Accelerating Research into Cures
The National Cancer Institute approved Hackensack Meridian Health John Theurer Cancer Center as a member of the Georgetown Lombardi Comprehensive Cancer Center Consortium.
About the Consortium
John Theurer Cancer Center, part of Georgetown Lombardi Comprehensive Cancer Center, an NCI designated comprehensive cancer center.
New Collaboration.New Discoveries.New Cures.
The National Cancer Institute approved Hackensack Meridian Health John Theurer Cancer Center as a member of the Georgetown Lombardi Comprehensive Cancer Center Consortium. John Theurer Cancer Center is now a member of one of just 16 cancer collaboratives based at the nation’s most prestigious institutions. The consortium enables both organization to continue their research at the highest level to deliver tomorrows breakthroughs in cancer cures today.
Together, we are working to solve some of the biggest challenges in cancer today, increasing access and understanding how we can treat cancer to achieve outcomes equally across our diverse communities.
History of NCI
In signing the National Cancer Act in 1971, President Nixon initiated a coordinated nationwide effort to find cures for all forms of cancer by increased research to improve the understanding of cancer biology and development of more effective treatment. Central to accelerating cures was the creation and funding of NCI-designated cancer centers where scientist and clinicians collaboratively aim their efforts to translate basic discovery into cures.
Our Expansive Clinical Trials Program
Clinical trials provide patients with the earliest access to the newest and most promising cancer therapies.Learn More
Understanding a Diagnosis
Want to learn more about what this means for our patients and for others who may be facing a cancer diagnosis? Contact us to speak with a nurse.Call 551-996-5855